| Circular RNA ciRS-7 triggers the migration and invasion of esophageal squamous cell carcinoma via miR-7/KLF4 and NF-kappa B signals |
42 |
| Life and death of circulating cell-free DNA |
33 |
| LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway |
23 |
| LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway |
22 |
| Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway |
21 |
| Breast cancer lung metastasis: Molecular biology and therapeutic implications |
21 |
| M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression |
19 |
| Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p |
19 |
| LncRNA DUXAP10 modulates cell proliferation in esophageal squamous cell carcinoma through epigenetically silencing p21 |
19 |
| A regulatory circuit of circ-MTO1/miR-17/QKI-5 inhibits the proliferation of lung adenocarcinoma |
18 |
| Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer |
18 |
| KCNQ1OT1/miR-217/ZEB1 feedback loop facilitates cell migration and epithelial-mesenchymal transition in colorectal cancer |
18 |
| Current state of melanoma diagnosis and treatment |
16 |
| MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55 |
16 |
| Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma |
16 |
| LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5 |
16 |
| Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer |
16 |
| Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway |
15 |
| Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study |
15 |
| PD1 protein expression in tumor infiltrated lymphocytes rather than PDL1 in tumor cells predicts survival in triple-negative breast cancer |
15 |
| MiR-135a-5p represses proliferation of HNSCC by targeting HOXA10 |
15 |
| The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis |
14 |
| MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4 |
14 |
| Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma |
14 |
| Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1 |
13 |
| miR-506 is a YAP1-dependent tumor suppressor in laryngeal squamous cell carcinoma |
13 |
| Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma |
12 |
| Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features |
12 |
| Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis |
12 |
| The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study |
12 |
| Circ0043898 acts as a tumor inhibitor and performs regulatory effect on the inhibition of esophageal carcinoma |
11 |
| Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer |
11 |
| Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a |
11 |
| STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway |
11 |
| The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis |
11 |
| iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma |
10 |
| Double amplifications of CDK4 and MDM2 in a gastric inflammatory myofibroblastic tumor mimicking cancer with local invasion of the spleen and diaphragm |
10 |
| EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/beta-catenin signaling pathway |
10 |
| MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2 |
9 |
| UBE2C promotes rectal carcinoma via miR-381 |
9 |
| Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses |
9 |
| MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1 |
9 |
| Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, G alpha(q) and G alpha(11) and kill uveal melanoma cells |
9 |
| Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior |
9 |
| Natural dietary compound naringin prevents azoxymethane/dextran sodium sulfate-induced chronic colorectal inflammation and carcinogenesis in mice |
9 |
| The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC) |
8 |
| Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient |
8 |
| Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis |
8 |
| Anti-cancer effects of the HuR inhibitor, MS- in malignant glioma cells |
8 |
| LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis |
8 |
